Evidence map›Paper›PMID 34957609›Full record

ArticleJournal of clinical laboratory analysis2022

The diagnostic role of PD-1

Ji-Wen Fan, Lin Yan, Xue-Qiao Wang, Ya-Mei Li, Yang-Juan Bai, Xiao-Qi Ou, Zheng-Li Wan, Yi Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical laboratory analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. The diagnostic role of PD-1Journal of clinical laboratory analysis · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ji-Wen FanDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Sichuan University, Chengdu, Sichuan Province, China.
Lin YanDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Sichuan University, Chengdu, Sichuan Province, China.
Xue-Qiao WangDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Sichuan University, Chengdu, Sichuan Province, China.
Ya-Mei LiDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Sichuan University, Chengdu, Sichuan Province, China.
Yang-Juan BaiDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Sichuan University, Chengdu, Sichuan Province, China.
Xiao-Qi OuDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Sichuan University, Chengdu, Sichuan Province, China.
Zheng-Li WanDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Sichuan University, Chengdu, Sichuan Province, China.
Yi LiDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Sichuan University, Chengdu, Sichuan Province, China.ORCID https://orcid.org/0000-0003-0418-3521
Sichuan University · CN

Funding

1·3·5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University 19HXFH023Key Research and Development Project of the Department of Science and Technology of Sichuan Province 2019YFS0284Key Research and Development Project of the Department of Science and Technology of Sichuan Province 2019YFS0287Key Research and Development Project of the Department of Science and Technology of Sichuan Province 2020YFS0228Key Research and Development Project of the Department of Science and Technology of Sichuan Province 2021YFS0160The National Natural Science Foundation of China 82102466
6 · The paper itself

Abstract

backgroundThe roles of PD-1

methods82 KTRs were enrolled in this study. 45 KTRs were included in the chronic allograft dysfunction (CAD) group, and 37 KTRs were included in the stable recipients group. Among the CAD group, 12 cases of antibody-mediated rejection (ABMR) and 4 cases of T cell-mediated rejection (TCMR) were diagnosed by biopsy. The percentage of CXCR5

resultsThe expression of CXCR5 on CD3

conclusionsOur results suggested that PD-1

Indexed as

Kidney TransplantationAdultAllograftsBiomarkersCD8-Positive T-LymphocytesFemaleGraft RejectionHumansKidneyLogistic ModelsMaleMiddle AgedProgrammed Cell Death 1 ReceptorReceptors, CXCR5ROC CurveT Follicular Helper CellsBiomarkersCXCR5 protein, humanProgrammed Cell Death 1 ReceptorReceptors, CXCR5ABMRchronic renal allograft dysfunctionCXCR5+CD8+ T cellskidney transplantPD-1

Identifiers

PMID34957609
PMCPMC8842189
OpenAlexW4200007836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.